Investing.com - BeiGene reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
BeiGene announced earnings per share of $-5.23 on revenue of $149.99M. Analysts polled by Investing.com anticipated EPS of $-3.79 on revenue of $172.1M.
BeiGene shares are up 28% from the beginning of the year and are trading at $335.88 , down-from-52-week-high.They are outperforming the S&P 500 which is up 17.92% from the start of the year.
BeiGene follows other major Healthcare sector earnings this month
BeiGene's report follows an earnings beat by J&J on Wednesday, July 21, 2021, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on Thursday, July 15, 2021 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar